Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07407426 · ClinicalTrials.gov registry record · NA
EEG-Guided Binaural Beat Audio to Reduce Performance-Related Stress and Improve Cognition
A NA study, sponsored by Texas Tech University Health Sciences Center.
- Not yet
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT07407426: Clinical Trial NA study, sponsored by Texas Tech University Health Sciences Center.
NCT07407426 is a NA study that has not yet begun recruiting, run by Texas Tech University Health Sciences Center. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07407426, a NA study, has not yet begun recruiting, sponsored by Texas Tech University Health Sciences Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Performance-related stress can impair sustained attention, inhibitory control, and memory. This randomized, double-blinded, sham-controlled parallel-arm trial evaluates whether a 30-minute EEG-guided binaural beat audio intervention reduces subjective stress/performance anxiety and improves cognition, and whether it changes task-related brain reactivity measured by fMRI. The intervention uses real-time single-electrode EEG recorded over the left prefrontal cortex to dynamically adjust binaural beat frequencies to guide the brain toward a target state; the sham condition uses non-binaural music delivered through identical headphones. Adult music majors preparing for an upcoming concert will complete pre- and post-intervention fMRI sessions during cognitive/music tasks (Stop Signal Reaction Task, Music Reading Task, Music Memory Retrieval Task) and complete visual analog scales (VAS) assessing performance anxiety, stress, and related subjective states. The primary outcomes include fMRI task-related activity in stress-regulation regions (dlPFC, amygdala, hippocampus), behavioral inhibition indices from the stop-signal task, music memory retrieval accuracy, and VAS-reported stress/performance anxiety.
Primary Outcome
fMRI task-related activity in dlPFC, amygdala, and hippocampus during SSRT.
Interventions
- OTHER EEG-guided binaural beat audio
- OTHER Non-binaural audio intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2026-04-07 |
| Est. Completion | 2026-08-30 |
| Phase | NA |
What is known before NCT07407426 opens enrollment
NCT07407426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which EEG-guided binaural beat audio is the first listed.
NCT07407426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07407426 about?
NCT07407426 is a clinical study titled "EEG-Guided Binaural Beat Audio to Reduce Performance-Related Stress and Improve Cognition". Performance-related stress can impair sustained attention, inhibitory control, and memory. This randomized, double-blinded, sham-controlled parallel-arm trial evaluates whether a 30-minute EEG-guided binaural beat audio intervention reduces subjective stress/performance anxiety and improves cognitio...
What is the current status of trial NCT07407426?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2026-04-07. Estimated completion is 2026-08-30.
What interventions are being tested in trial NCT07407426?
The interventions under investigation include: EEG-guided binaural beat audio (OTHER), Non-binaural audio intervention (OTHER).
Who is sponsoring clinical trial NCT07407426?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07407426's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI